Best Practices Along the Tissue Journey in NSCLC
The Evolving Treatment Landscape in Relapsed/Refractory Follicular Lymphoma
Clinical Scenarios: Treatment Decisions in Non-Small Cell Lung Cancer
Practical Approaches to Treatment in Breast Cancer
Translating Evidence to Clinical Practice to Improve Outcomes in Patients with Small Cell Lung Cancer
Exploring Recent Developments in the Treatment of Patients with HR+ Metastatic Breast Cancer
Bruton Tyrosine Kinase (BTK) Inhibitors in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
Practical Approaches to Treatment in Patients with Breast Cancer
Clinical Scenarios: Treating Patients with Gastric Cancer
Sponsored by Daiichi Sankyo. Content independently developed by OncLive®.
Multidisciplinary Management of Patients with Basal Cell Carcinoma
New Directions in CLL
Treatment Decisions in Non-Small Cell Lung Cancer
Evolving Approaches in the Treatment of AML and MDS
Sponsored in part by Servier Pharmaceuticals. Content independently developed by OncLive.
HER2 Biomarker Testing in Breast and Gastrointestinal Cancers: The Role of the Pathologist
Funding from Daiichi Sankyo; Content Developed Independently by OncLive.
Current and Emerging Trends in Breast Cancer: HER2+ and HER2-Low
Treatment Updates and Advances in Cervical Cancer
Current and Emerging Trends in Breast Cancer: HER2 + and HER2-Low: An OncLive® Scientific Interchange and Workshop
Sponsored in part by Daiichi Sankyo. Content independently developed by OncLive®
Current and Future Trends in Myelofibrosis: Cytopenias
Community Perspectives in Non-Small Cell Lung Cancer
Academic Perspectives in Non-Small Cell Lung Cancer
Updates in the Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Updates in the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia
Advances in Risk-Stratification and Therapeutic Options for Early-Stage Non–Small Cell Lung Cancer
Updates in the Treatment of Waldenström Macroglobulinemia
Molecular Targets on the Horizon in Non–Small Cell Lung Cancer
Sponsored in part by Daiichi Sankyo. Content independently developed by OncLive.
Updates in the Treatment of Mantle Cell Lymphoma
Treatment Considerations in Relapsed Refractory Multiple Myeloma
Updates in the Treatment of Diffuse Large B-cell Lymphoma
Understanding the Evolving Role of PI3K Inhibitors in the Treatment of Follicular Lymphoma
Updates in ALK-Positive Non–Small Cell Lung Cancer
Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer
As Orthopedic Oncology Evolves, Caring for the Clinician Must Be a Priority
Belumosudil Produces Long-Term Responses Without New Safety Concerns in cGVHD
Prophylactic Itacitinib May Safely Mitigate CRS Following Axi-Cel Administration in Lymphoma
